Internationalvaccineinstitute

11/22/2018

THSTI, IVI held joint symposium on Nov. 22

First cooperative program between International Vaccine Institute and Translational Health Science and Technology Institute expected to help accelerate cooperation between India and IVI IVI and the Translational Health Science and Technology Institute (THSTI) of India held a joint symposium at IVI headquarters on November 22. […]
11/30/2018

Scientific Advisory Group (SAG) gathers for 17th meeting

Sharing new developments and ideas in vaccinology throughout the day IVI’s Scientific Advisory Group (SAG) convened at IVI headquarters in Seoul on November 15 for their 17th annual two-day-long meeting. This event brings together IVI scientists and members of the SAG. The SAG consists of […]
11/30/2018

BOT meets face-to-face and visits KCDC & LG Chem’s vaccine plant

Members of the IVI Board of Trustees On Nov. 19, 2018, IVI’s Board of Trustees convened at IVI headquarters in Seoul for their second face-to-face meeting of the year. This was followed by a visit to the Korea Center for Disease Control (KCDC) on Nov. […]
12/12/2018

Nature Communications study addresses MDR typhoid

New study in Nature Communications reveals high burden of multi-drug resistant (MDR) typhoid fever in sub-Saharan Africa associated with two predominant genotypes – IVI epidemiologist Se Eun Park and collaborating scientists report data from Typhoid Fever Surveillance in Africa (TSAP) program and other sources   […]